Home Compare AZN.L vs EXPN.L
Stock Comparison · Structural lead, mixed market

AstraZeneca vs Experian: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Experian carrying a narrow edge on growth. AstraZeneca still has the edge on stability, which keeps the comparison from looking entirely one-sided. In the market, AstraZeneca carries the stronger setup — intact trend against Experian's broken trend. That leaves a split case: the structural lead stays with Experian, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the STOXX 600 universe, making them directly comparable.

Updated 2026-07-05

The clearest score difference appears in growth, while profitability still leans the other way.

Trajectory Similarity
0.62
Moderately similar
Peer-set rank: #12
within AstraZeneca PLC's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The strongest overlap appears in capital structure and operating margin level.

Similarity drivers
capital structureoperating margin level
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
AZN.L
AstraZeneca PLC
50
Peer-Score
Signal qualityHigh
Peer basis: STOXX 600
vs
EXPN.L
Experian plc
54
Peer-Score
Signal qualityMedium
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: AZN.L vs EXPN.L Profitability 44 37 Stability 68 45 Valuation 43 63 Growth 50 74 AZN.L EXPN.L
Gap Ranking
#1 Growth +24
#2 Stability +23
#3 Valuation +20
#4 Profitability +7
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AZN.L and EXPN.L Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AZN.LEXPN.L Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against AstraZeneca PLC.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Both rank well on growth, but Experian plc still sits higher.
Stability
On stability, the edge is clear — both rank well, but AstraZeneca PLC sits noticeably higher.
Growth — Dominant Gap
AZN.L
50
EXPN.L
74
Gap+24in favour of EXPN.L

The clearest distance comes from a stronger growth profile.

What keeps the gap from being one-sided

There is still a strong counterforce in stability, so the lead stays clear without becoming a sweep.

What this means for the comparison

Growth gives Experian plc the clearer edge, even though stability and the price setup keep the overall picture from looking clean.

Explore full peer positioning in AssetNext

Break down the AZN.L vs EXPN.L comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how AZN.L and EXPN.L each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.